Association Between Invasive Disease–Free Survival and Biomarkers in Patients With Residual Invasive Breast Cancer After Neoadjuvant Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Biomarker Data From the Phase III KATHERINE Study of Adjuvant T-DM1 Versus Trastuzumab for Residual Invasive Disease After Neoadjuvant Therapy for HER2-Positive Breast Cancer
Clin. Cancer Res 2023 Feb 02;[EPub Ahead of Print], C Denkert, C Lambertini, PA Fasching, KL Pogue-Geile, MS Mano, M Untch, N Wolmark, CS Huang, S Loibl, EPP Mamounas, CE Geyer, PC Lucas, T Boulet, C Song, GD Lewis, M Nowicka, S de Haas, M BasikFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.